731P Multi-maintenance olaparib in relapsed, platinum-sensitive BRCA-mutant high-grade serous ovarian carcinoma (MOLTO): A phase II feasibility study

• DOI: 10.1016/j.annonc.2021.08.1174
• Publication Date: 2021-09-21T19:00:28Z
• Authors: R.D. Morgan; A.R. Clamp; W.D.J. Ryder; C. Wheeler; E. Buckley; J. Truelove; A.D. Murphy; J. Hasan; C.L. Mitchell; G.J. Burghel; D. White; M. Price; S.S. Bhaskar; J. Shaw; C. Dive; A.J. Wallace; J.P. O'Connor; D. Rothwell; R.J. Edmondson; G.C. Jayson
• Keywords: Olaparib; BRCA Mutation